PATENT CLAIM ANALYSIS

Application Number: 16054231
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["424", "147100"]

Abstract:
The present invention is an antibody including an amino acid sequence, wherein the amino acid sequence includes, in an N- to C-direction, the following structural domains: N-FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4-C wherein FR denotes a framework region amino acid sequence and CDR denotes a complementary determining region amino acid sequence; the CDR1 includes an amino acid sequence represented by SEQ ID NO: 1; the CDR2 includes an amino acid sequence represented by SEQ ID NO: 2; the CDR3 includes an amino acid sequence represented by SEQ ID NO: 3; and the antibody is capable of binding to an intranuclear protein of an influenza virus.

Claim (Index 7):
A detection device comprising:\n a composite according to  claim 4 ; and a detector; wherein the detector detects a change of a physical amount based on an antigen-antibody reaction of the composite and the intranuclear protein which is contained in an analyte.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 96.0
- Lexical Diversity: 2.15385
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16054220', '15648287', '15649279', '15970597', '15970563']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8191732802002764
- 35 USC 102 Novelty (BERT): 0.6373834881196403
- Combined Prediction Score: 0.8009943009922128
- Mean Citation Score: 560.8748659999999
- Max Citation Score: 628.86633
- Similarity Product: 571.8273101636768

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test